-
1.
公开(公告)号:EP4362923A1
公开(公告)日:2024-05-08
申请号:EP22834075.8
申请日:2022-06-28
IPC分类号: A61K31/00 , A61K31/015 , A61K31/12 , A61K31/66
CPC分类号: C07C205/45 , C07F9/3808 , C07F9/12
-
2.
公开(公告)号:EP2173702B1
公开(公告)日:2018-07-04
申请号:EP06791291.5
申请日:2006-05-10
发明人: GOOSSEN, Lukas , DENG, Guo-Jun,
IPC分类号: C07C201/12 , C07C253/30 , C07C255/64 , C07C41/30 , C07C25/18 , C07C315/04 , C07C317/14 , C07C209/68 , C07C49/78 , C07C25/24 , C07C49/84 , C07C45/72 , C07C45/68 , C07C211/55 , C07C233/07 , C07C319/20 , C07C205/57 , C07C43/205 , C07B37/04 , B01J31/26
CPC分类号: C07D333/08 , B01J27/122 , B01J27/232 , B01J31/1815 , B01J31/183 , B01J31/2234 , B01J31/2404 , B01J31/26 , B01J2231/4205 , B01J2531/0241 , B01J2531/16 , B01J2531/17 , B01J2531/824 , C07B37/04 , C07C1/26 , C07C17/263 , C07C17/2637 , C07C17/266 , C07C41/30 , C07C45/68 , C07C45/72 , C07C201/12 , C07C209/68 , C07C231/12 , C07C253/30 , C07C315/04 , C07C319/20 , C07C2527/122 , C07C2531/24 , C07C2531/28 , C07C2531/30 , C07C2603/26 , C07C15/52 , C07C25/18 , C07C25/24 , C07C49/782 , C07C47/546 , C07C49/84 , C07C317/14 , C07C211/55 , C07C233/07 , C07C255/64 , C07C323/09 , C07C205/06 , C07C205/11 , C07C205/35 , C07C205/44 , C07C205/45 , C07C205/57 , C07C43/205
-
3.INDENONCARBOXYLIC ACIDS DERIVATIVES AND THEIR USE FOR THE TREATMENT OF AND PREVENTING DIABETES AND DYSLIPIDAEMIA 有权
标题翻译: INDENONCARBONSÄUREN衍生物及其治疗和预防糖尿病和血脂异常公开(公告)号:EP1583738B1
公开(公告)日:2017-05-10
申请号:EP03785831.3
申请日:2003-12-16
申请人: Merck Patent GmbH
发明人: ADJE, Nathalie , BRUNET, Michel , ROCHE, Didier , ZEILLER, Jean-Jacques , YVON, Stéphane , GUYARD-DANGREMONT, Valérie , CONTARD, Francis , GUERRIER, Daniel , FERRAND, Gérard , BONHOMME, Yves
IPC分类号: C07C309/65 , C07C49/755 , C07C49/747 , C07C59/125 , C07C69/708 , C07C69/78 , C07C65/21 , C07C59/60 , C07C69/734 , C07C229/18 , C07C255/40 , C07C69/712 , C07C323/56 , C07C323/52 , A61K31/215 , A61K31/185 , A61P3/10 , A61P3/06 , C07C323/34 , C07C233/76 , C07C211/60
CPC分类号: C07C323/56 , C07C45/46 , C07C45/673 , C07C45/68 , C07C49/747 , C07C49/755 , C07C59/72 , C07C59/90 , C07C65/40 , C07C67/30 , C07C67/31 , C07C69/712 , C07C69/736 , C07C69/76 , C07C205/45 , C07C211/60 , C07C229/18 , C07C233/33 , C07C251/44 , C07C255/40 , C07C309/65 , C07C317/44 , C07C323/22 , C07C323/52 , C07C2602/08 , C07C2602/10 , C07C2602/42 , C07C47/575
-
公开(公告)号:EP1537066B1
公开(公告)日:2017-01-25
申请号:EP03766493.5
申请日:2003-08-06
申请人: Biogem s.c.ar.l
发明人: ROBERTS, Stanley M., , SANTORO, Maria Gabriella, Uni. of Rome Department of Biology , HAPPE, Alan M. , DAUVERGNE, Jérôme , JADHAV, Vasudev
IPC分类号: C07C49/683
CPC分类号: C07C323/59 , C07C45/673 , C07C49/647 , C07C49/653 , C07C49/657 , C07C49/753 , C07C205/45 , C07C225/20 , C07C233/32 , C07C233/76 , C07C271/24 , C07C271/36 , C07C271/56 , C07C271/66 , C07C311/20 , C07C311/53 , C07C323/43 , C07C2601/08 , C07C2601/10
-
5.Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives 有权
标题翻译: 一种用于5 - 卤代烷基-4,5-二氢异恶唑衍生物的制备方法公开(公告)号:EP2176244B1
公开(公告)日:2016-06-01
申请号:EP08797091.9
申请日:2008-08-04
IPC分类号: C07D261/04 , C07D413/10 , C07D413/12 , C07D417/12 , C07C49/235
CPC分类号: C07D261/04 , C07C45/65 , C07C45/68 , C07C45/72 , C07C49/813 , C07C49/83 , C07C49/835 , C07C49/84 , C07C65/38 , C07C69/007 , C07C201/12 , C07C205/45 , C07D413/10 , C07D413/12 , C07D417/12
-
公开(公告)号:EP1378505B1
公开(公告)日:2014-11-05
申请号:EP02703874.4
申请日:2002-02-21
发明人: OGAWA, Takanori, Kabushiki Kaisha Yakult Honsha , NISHIYAMA, Hiroyuki, Kabushiki K. Yakult Honsha , UCHIDA, Miyuki, Kabushiki Kaisha Yakult Honsha , SAWADA, Seigo, Kabushiki Kaisha Yakult Honsha
IPC分类号: C07C221/00 , C07C225/22 , C07C205/37 , C07C205/45 , C07D491/147
CPC分类号: C07D213/64 , C07C205/22 , C07C205/37 , C07C205/44 , C07C205/45 , C07C225/22 , C07D491/04 , C07D491/14 , Y02P20/55
-
7.NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER 有权
标题翻译: 核受体调节剂及其治疗和预防癌症的应用公开(公告)号:EP2721003A4
公开(公告)日:2014-10-29
申请号:EP12800764
申请日:2012-06-15
申请人: US HEALTH
发明人: NECKERS JANE B , KIM YEONG SANG , LEE SUNMIN , KUMAR VINEET , MALHOTRA SANJAY V
IPC分类号: C07C255/50 , A61K9/10 , A61K31/12 , A61P35/00 , C07C49/235 , C07C49/796 , C07C317/44
CPC分类号: C07C49/796 , A61K31/12 , A61K31/275 , A61K45/06 , C07C49/80 , C07C49/813 , C07C49/84 , C07C205/45 , C07C255/56 , A61K2300/00
摘要: Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.
摘要翻译: 公开的是可以作为雄激素受体的拮抗剂的核受体调节剂的化合物,例如式I的化合物:其中R 1至R 5和X 1至X 5如本文所述,以及其药学上可接受的盐,溶剂合物和 其立体异构体。 还公开了包含这些化合物的药物组合物,以及使用方法和治疗癌症,包括前列腺癌,其他核受体介导的癌症和其它病症。
-
8.NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER 有权
标题翻译: 核受体调节剂和它们用于治疗和预防癌症公开(公告)号:EP2721003A1
公开(公告)日:2014-04-23
申请号:EP12800764.8
申请日:2012-06-15
IPC分类号: C07C255/50 , C07C317/44 , C07C49/796 , C07C49/235 , A61K9/10 , A61K31/12 , A61P35/00
CPC分类号: C07C49/796 , A61K31/12 , A61K31/275 , A61K45/06 , C07C49/80 , C07C49/813 , C07C49/84 , C07C205/45 , C07C255/56 , A61K2300/00
摘要: Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R
1 to R
5 and X
1 to X
5 are as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.-
9.PROCESS FOR PREPARING INDOL-5-OXY-QUINAZOLINE DERIVATIVES AND INTERMEDIATES 审中-公开
标题翻译: 一种用于吲哚-5-基氧基 - 喹唑啉衍生物和中间体的制备方法。公开(公告)号:EP2540705A3
公开(公告)日:2013-10-30
申请号:EP12175034.3
申请日:2007-11-01
发明人: Arnott, Euan, Alexander , Crosby, John , Evans, Matthew, Charles , Ford, James, Gair , Jones, Martin, Francis , Leslie, Kevin, William , Mcfarlane, Ian, Michael , Sependa, George, Joseph
IPC分类号: C07D209/08 , C07D239/88 , C07D403/12 , C07C69/732 , C07D487/10 , C07D207/06
CPC分类号: C07D209/08 , C07C201/12 , C07C205/45 , C07C205/56 , C07D207/06 , C07D239/88 , C07D403/12 , C07D487/10 , Y02P20/55
摘要: The present invention relates to chemical processes for the manufacture of certain quinazoline derivatives, or pharmaceutically acceptable salts thereof. The invention also relates to processes for the manufacture of certain intermediates useful in the manufacture of the quinazoline derivatives and to processes for the manufacture of the quinazoline derivatives utilising said intermediates. In particular, the present invention relates to chemical processes and intermediates useful in the manufacture of the compound 4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline.
-
10.
公开(公告)号:EP2168940B1
公开(公告)日:2013-07-24
申请号:EP08751832.0
申请日:2008-04-03
IPC分类号: C07C49/203 , A61K8/35 , A61Q13/00 , C07C45/29 , C07C45/59 , C07C45/68 , C11B9/00 , C07F9/54 , C07C17/16 , C07C45/00 , C07C205/44
CPC分类号: C07C49/203 , A61K8/35 , A61Q13/00 , C07C17/16 , C07C45/00 , C07C45/29 , C07C45/59 , C07C45/68 , C07C205/44 , C07C205/45 , C07F9/5442 , C11B9/0015 , C07C21/14 , C07C49/185
-
-
-
-
-
-
-
-
-